![]() |
|
|
Vol. 58, Issue 1, 48-57, July 2000
Department of Oncology and the Environmental Toxicology Program,
McArdle Laboratory for Cancer Research, University of Wisconsin,
Madison, Wisconsin
Glucocorticoid inducibility of the CYP3A23 gene is
conferred by a multisite unit comprising binding sites for several
members of the nuclear receptor superfamily of transcription factors, including the chicken ovalbumin upstream promoter-transcription factor
COUP-TF, pregnane X receptor (PXR), and hepatocyte nuclear factor 4 (HNF-4). The presence of three binding sites, each of which
interacts with more than one factor, contributes to the complexity of
the CYP3A23 glucocorticoid-responsive region. Despite the glucocorticoid sensitivity of this gene, direct binding of ligand-activated glucocorticoid receptor (GR) to the
CYP3A23 dexamethasone-responsive region (DexRE) is not
required for induction. This study demonstrates that DexRE-2 is the key
element within the CYP3A23 proximal promoter, conferring
ligand sensitivity via its interaction with the PXR/RXR
heterodimer. The DexRE-1 and HNF-4 sites are not ligand-responsive, but
are essential accessory elements required for full promoter inducibility. In addition to ligand-mediated activation of PXR, the
overall induction response involves a GR-mediated stimulation of PXR
and RXR
expression. Hence, the induction pathway can be divided into
two stages. In stage one, maximal induction requires a GR-dependent
increase in PXR and RXR
expression, and stage two is characterized
by direct transcriptional activation of CYP3A23, which
is dependent on ligand-activated PXR as well as accessory factors bound
at the DexRE-1 and HNF-4 sites. Because multiple proteins bind at each
element within the glucocorticoid-responsive region, factors not
contributing to ligand responsiveness, such as chicken ovalbumin
upstream promoter-transcription factor, may modulate the response
through competitive interactions.
This article has been cited by other articles:
![]() |
B. W. Cooper, T. M. Cho, P. M. Thompson, and A. D. Wallace Phthalate Induction of CYP3A4 is Dependent on Glucocorticoid Regulation of PXR Expression Toxicol. Sci., June 1, 2008; 103(2): 268 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bhadhprasit, T. Sakuma, N. Hatakeyama, M. Fuwa, K. Kitajima, and N. Nemoto Involvement of Glucocorticoid Receptor and Pregnane X Receptor in the Regulation of Mouse CYP3A44 Female-Predominant Expression by Glucocorticoid Hormone Drug Metab. Dispos., October 1, 2007; 35(10): 1880 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Swales, S. Kakizaki, Y. Yamamoto, K. Inoue, K. Kobayashi, and M. Negishi Novel CAR-mediated Mechanism for Synergistic Activation of Two Distinct Elements within the Human Cytochrome P450 2B6 Gene in HepG2 Cells J. Biol. Chem., February 4, 2005; 280(5): 3458 - 3466. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Phillips, S. R. Hood, G. G. Gibson, and N. J. Plant IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION Drug Metab. Dispos., February 1, 2005; 33(2): 233 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, Y. Li, J. Liu, M. Mukundan, and B. Yan Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 571 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Turncliff, P. J. Meier, and K. L. R. Brouwer EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES Drug Metab. Dispos., August 1, 2004; 32(8): 834 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, M. Xie, H. Zhang, Y. Li, K. Sachdeva, and B. Yan THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES Drug Metab. Dispos., January 1, 2004; 32(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kliewer, B. Goodwin, and T. M. Willson The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism Endocr. Rev., October 1, 2002; 23(5): 687 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Ripp, J. L. Fitzpatrick, J. M. Peters, and R. A. Prough Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor Drug Metab. Dispos., May 1, 2002; 30(5): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Zangar, A. L. Kimzey, J. R. Okita, D. S. Wunschel, R. J. Edwards, H. Kim, and R. T. Okita Cytochrome P450 3A Conjugation to Ubiquitin in a Process Distinct from Classical Ubiquitination Pathway Mol. Pharmacol., April 1, 2002; 61(4): 892 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Falkner, J. A. Pinaire, G.-H. Xiao, T. E. Geoghegan, and R. A. Prough Regulation of the Rat Glutathione S-Transferase A2 Gene by Glucocorticoids: Involvement of Both the Glucocorticoid and Pregnane X Receptors Mol. Pharmacol., September 1, 2001; 60(3): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Quattrochi and P. S. Guzelian CYP3A Regulation: From Pharmacology to Nuclear Receptors Drug Metab. Dispos., April 13, 2001; 29(5): 615 - 622. [Abstract] [Full Text] |
||||
![]() |
A. Geick, M. Eichelbaum, and O. Burk Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin J. Biol. Chem., April 27, 2001; 276(18): 14581 - 14587. [Abstract] [Full Text] [PDF] |
||||